2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyrid-2yl]-methylthio]benzimidazole 98%

Since its inception in 1992, Ultratech has established itself as a trans-national company manufacturing world-class Pharmaceutical products with a diverse product portfolio that includes Pharmaceutical Ethical Drugs, OTC, Nutraceutical and Cosmetic Products for a broad spectrum of applications. In its two decade journey, the company has established its clientele in more than 25 Countries. Ultratech provides its Active Pharmaceutical Ingredients to innovator and generic companies globally. The company has a broad portfolio of Finished Dosage Forms in various therapeutic segments and has developed its niche in pulmonary drug delivery systems and offers a complete range of anti-asthmatic inhalation drugs in Dry Powder Inhalation and Pressurized Metered Dose Inhalation dosage forms.